Chair(s)
MSc.Pharm Peter Thøgersen, Pharmadanmark, Denmark & Prof. Giovanni Pauletti, FIP Board of Pharmaceutical Sciences, USA
Introduction:
As antimicrobial resistance continues to challenge the effectiveness of existing treatments, the search for novel antimicrobial agents is gaining momentum. Advances in areas such as gene editing and computational medicinal chemistry are supporting innovative approaches to drug discovery. This session will explore the potential of CRISPR technology in targeting infectious diseases and examine scientific and practical considerations in developing the next generation of antibiotics. Through examples from research and industry, the session will consider how these tools are being applied to expand the antimicrobial pipeline.
Programme:
| 13:00 – 13:05 | Introduction by the chairs |
| 13:05 – 13:30 | The use of clustered regularly interspaced short palindromic repeats (CRISPR) technology in developing novel treatments against infection diseases |
| Dr Christian Grøndahl, SNIPR Biome, Denmark | |
| 13:30 – 13:55 | Developing the next generation antibiotics – challenges and opportunities |
| Prof. Anders Karlén, Uppsala University, Sweden | |
| 13:55 – 14:00 | Closing by the chairs |
